您的位置: 首页 > 农业专利 > 详情页

NOUVEAUX PEPTIDES ET COMBINAISONS DE PEPTIDES ET ECHAFAUDAGES FORMES DE CEUX-CI DESTINES A ETRE UTILISES EN IMMUNOTHERAPIE CONTRE LE CARCINOME COLORECTAL (CRC) ET D'AUTRES CANCERS
专利权人:
IMMATICS BIOTECHNOLOGIES GMBH
发明人:
MAHR, ANDREA,WEINSCHENK, TONI,WIEBE, ANITA,FRITSCHE, JENS,SINGH, HARPREET,SCHOOR, OLIVER
申请号:
CA2984123
公开号:
CA2984123A1
申请日:
2016.05.04
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充